ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK

Heart
Kornelia KotsevaASPIRE-2-PREVENT Study Group

Abstract

To determine in patients with coronary heart disease (CHD) and people at high risk of developing cardiovascular disease (CVD) whether the Joint British Societies' guidelines on CVD prevention (JBS2) are followed in everyday clinical practice. A cross-sectional survey was undertaken of medical records and patient interviews and examinations at least 6 months after the recruiting event or diagnosis using standardised instruments and a central laboratory for measurement of lipids and glucose. The ASPIRE-2-PREVENT survey was undertaken in 19 randomly selected hospitals and 19 randomly selected general practices in 12 geographical regions in England, Northern Ireland, Wales and Scotland. In hospitals, 1474 consecutive patients with CHD were identified and 676 (25.6% women) were interviewed. In general practice, 943 people at high CVD risk were identified and 446 (46.5% women) were interviewed. The prevalence of risk factors in patients with CHD and high-risk individuals was, respectively: smoking 14.1%, 13.3%; obesity 38%, 50.2%; not reaching physical activity target 83.3%, 85.4%; blood pressure ≥130/80 mm Hg (patients with CHD and self-reported diabetes) or ≥140/85 mm Hg (high-risk individuals) 46.9%, 51.3%; total cholesterol ≥4 mm...Continue Reading

Citations

Sep 7, 2013·Heart·Shahed Islam, Adam Timmis
Dec 4, 2013·Wiener klinische Wochenschrift·Shahed Islam, Adam Timmis
Nov 20, 2013·International Journal of Clinical Practice·T M Reynolds
Jun 28, 2014·Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses·Mary BoydeLeanne Aitken
Jun 18, 2017·European Journal of Preventive Cardiology·Min ZhaoIan Graham
Feb 8, 2013·Therapeutic Advances in Cardiovascular Disease·Richard Kones
Aug 25, 2017·Scottish Medical Journal·Kelvin Kw ChengDonald G Grosset
Jul 29, 2017·European Heart Journal Supplements : Journal of the European Society of Cardiology·Michele Massimo GuliziaAttilio Maseri
May 2, 2020·Open Heart·Catriona S JenningsUNKNOWN ASPIRE-3-PREVENT Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.